Intelligence / Healthtech / PMA Approvals / Alcon Laboratories, LLC
Approvalsdevice change approved (PMA)30 Oct 2026
Alcon Laboratories, LLC
30 Oct 2026: Device change approved (PMA) · Clareon Vivity Pro Extended Vision IOLs. Recorded in the openFDA device PMA data.
- Decided
- 30 Oct 2026
- Device
- Clareon Vivity Pro Extended Vision IOLs
- Specialty
- Ophthalmic
- Type
- Supplement (Normal 180 Day Track)
- Reason
- Change Design/Components/Specifications/Material
- Reference
- P190018 S050
- Location
- Fort Worth, TX
What this signal means
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Alcon Laboratories, LLC
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in Ophthalmic
PMA Approvals
23 OctLenstec, INC.device change approved (PMA) · ClearView HD intraocular lens (IOL)Approvals24 SeptRayner Intraocular Lenses , LTD.device change approved (PMA) · RayOne Galaxy; Model RAO605G, RayOne Galaxy Toric; Model RAO615XApprovals
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.